Top 10 Pharmaceutical Stocks with Highest Return on Equity: BSTC, SNTS, HLF, ALXN, GSK, LLY, AZN, QCOR, CSKI, MRK (Mar 08, 2010)

Below are the top 10 Pharmaceutical stocks with highest Return on Equity ratio for the last 12 months. One Chinese company is on the list.

BioSpecifics Technologies Corp. (NASDAQ:BSTC) has the 1st highest Return on Equity in this segment of the market. Its ROE was 115.34% for the last 12 months. Its net profit margin was 39.56% for the same period. Santarus, Inc. (NASDAQ:SNTS) has the 2nd highest Return on Equity in this segment of the market. Its ROE was 114.21% for the last 12 months. Its net profit margin was 18.62% for the same period. Herbalife Ltd. (NYSE:HLF) has the 3rd highest Return on Equity in this segment of the market. Its ROE was 67.66% for the last 12 months. Its net profit margin was 8.75% for the same period. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has the 4th highest Return on Equity in this segment of the market. Its ROE was 63.11% for the last 12 months. Its net profit margin was 76.31% for the same period. GlaxoSmithKline plc (ADR) (NYSE:GSK) has the 5th highest Return on Equity in this segment of the market. Its ROE was 61.67% for the last 12 months. Its net profit margin was 19.98% for the same period.

Eli Lilly & Co. (NYSE:LLY) has the 6th highest Return on Equity in this segment of the market. Its ROE was 53.25% for the last 12 months. Its net profit margin was 19.82% for the same period. AstraZeneca plc (ADR) (NYSE:AZN) has the 7th highest Return on Equity in this segment of the market. Its ROE was 41.13% for the last 12 months. Its net profit margin was 23.00% for the same period. Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) has the 8th highest Return on Equity in this segment of the market. Its ROE was 36.50% for the last 12 months. Its net profit margin was 30.15% for the same period. China Sky One Medical, Inc. (NASDAQ:CSKI) has the 9th highest Return on Equity in this segment of the market. Its ROE was 34.34% for the last 12 months. Its net profit margin was 28.61% for the same period. Merck & Co., Inc. (NYSE:MRK) has the 10th highest Return on Equity in this segment of the market. Its ROE was 33.03% for the last 12 months. Its net profit margin was 47.48% for the same period.